FDA Investigator Jessica L Kocian
Jessica L Kocian has conducted inspections on 36 sites in 1 countries as of 11 Aug 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
36
Last Inspection Date:
11 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Jessica L Kocian:
Alan D Grupe,
Amy R Glynn,
Belinda E Clifton,
Brenda K Alford,
Brenda L Reihing,
Bruce R Burrell,
Bryce E Mansfield,
Christopher R Czajka,
Daniel A Congdon,
David A Quale,
David L Hunsaker,
Deborah A Nebenzahl,
Dennis R Hudson,
Eric C Milstead,
Eric L Scott,
Erica R Mahone,
Harmon M Blanch,
Heika R Tait,
Hugh A Grimoldby,
Ian J Thomson,
James I Vik,
Janelle K Martin,
Jean C Colon Lopez,
Jean R Mccurry,
Jeanne M Weishaar,
Jeffrey N Gerdes,
Jinkee Mvila Binayug,
John W Banks,
Jonathan T Little,
Julia E Chervoni,
Julie A Stocklin,
Katherine L Arnold,
Katherine L Ernest,
Keegan B Mixon,
Kelsey A Hustedt,
Kelsey A Volkman,
Kenneth O Gee, PhD,
Kimberly Jproctor Jones,
Lance W Bohm,
LCDR Ismael Olvera, IV,
Leon R Marquart,
Lester O Boian,
Lisa A Bowden,
Lisa K Capron,
Margo C Jones,
Mark E Imsland,
Mark E Moen,
Marsha L Mccauley,
Michael H Antee,
Michael J Donovan,
Michael S Hudson,
Nancy E Byerly,
Narahi J Alvarez Alcazar,
Paul M Kawamoto,
Paula J Wilkerson,
Rachel J Cantrell,
Rebecca A Sletner,
Richard A Martin,
Richard G Runyon,
Ronald E Gill,
Sandra K Wangen,
Shahriar Rahmani,
Shannon J Hall,
Sharon K Ferguson,
Shelagh D Schopen,
Sherri N Rohlf, MD,
Tara M Pianko,
Thomas C Mclean, CFS,
Vanessa Y Gelsey, PhD,
William A Burkey,
Willis L Hicks
Jessica L Kocian's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2011 | FDA 483 | Giant Greens, Inc. - Form 483, 2011-01-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more